Cobalamin and Uniphyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cobalamin (vitamin b12) and Uniphyl (theophylline). Common drug interactions include asthma among females.

The phase IV clinical study analyzes what interactions people have when they take Cobalamin and Uniphyl. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Cobalamin?

Cobalamin has active ingredients of vitamin b12. eHealthMe is studying from 3,429 Cobalamin users. Check the latest studies of Cobalamin.

What is Uniphyl?

Uniphyl has active ingredients of theophylline. eHealthMe is studying from 3,086 Uniphyl users. Check the latest studies of Uniphyl.



On Jul, 18, 2026

35 people who take Cobalamin and Uniphyl together, and have interactions are studied.

Cobalamin and Uniphyl drug interactions.

What are the common drug interactions of Cobalamin and Uniphyl, by gender? *:

female:

  1. Asthma
  2. Angina pectoris (chest pain due to ischemia of the heart muscle)
  3. Fall
  4. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  5. Influenza
  6. Injury
  7. Insomnia (sleeplessness)
  8. Lower respiratory tract infection
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

male:

n/a

What are the common drug interactions of Cobalamin and Uniphyl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Asthma
  2. Angina pectoris (chest pain due to ischemia of the heart muscle)
  3. Fall
  4. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  5. Influenza
  6. Injury
  7. Insomnia (sleeplessness)
  8. Lower respiratory tract infection
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

What are the existing conditions these people have? *

  1. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 31 people, 88.57%
  2. Asthma: 29 people, 82.86%
  3. Stable Angina (a constant chest pain): 9 people, 25.71%
  4. Fever: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Cobalamin and Uniphyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cobalamin and Uniphyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Uniphyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cobalamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Uniphyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on vitamin b12 and theophylline (the active ingredients of Cobalamin and Uniphyl, respectively), and Cobalamin and Uniphyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: